Barriers to glycemic control in youth with type 1 diabetes and type 2 diabetes

Pediatric Diabetes

Volumn 12, Issue 3 PART 1, 2011, Pages 197-205

  Anderson, Barbara J ^a   Mckay, Siripoom V ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Texas Children's Hospital   (United States)

Author keywords

Barriers; Glycemic control; Pediatric diabetes

Indexed keywords

GLUCOSE;

ADOLESCENCE; ADOLESCENT; CHILD; CHILD DEVELOPMENT; CULTURAL FACTOR; DIABETES CONTROL; FAMILY LIFE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; PATIENT COMPLIANCE; RISK FACTORS;

EID: 79955431680     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00667.x     Document Type: Review

References (81)

1. Wood JR, Laffel LM. Technology and intensive management in youth with type 1 diabetes: State of the art. Curr Diab Rep 2007: 7: 104-113.
2. Shalitin S, Phillip M. The role of new technologies in treating children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2007: 8: 72-79.
3. Chase HP, Arslanian S, White NH, Tamborlane WV. Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus. J Pediatr 2008: 153: 547-53.
4. Hassan K, Rodriguez LM, Johnson SE, Tadlock S, Heptulla RA. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes. Pediatrics 2008: 121: e466-e472.
5. Silverstein J, Klingensmith G, Copeland K et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005: 28: l86-212.
6. Pihoker C, Forsander G, Wolfsdorf J, Klingensmith GJ. The delivery of ambulatory diabetes care to children and adolescents with diabetes. ISPAD clinical practice consensus guidelines 2009. Pediatr Diabetes 2009: 10 (Suppl. 12): 58-70.
7. Stone ML, Walker JL, Chisholm D et al. The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycemic control: a randomized control trial. Pediatr Diabetes 2008: 9:326-34.
8. The TODAY Study Group. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle modification. Pediatr Diabetes 2007: 8: 74-87.
9. Krentz AJ. Management of type 2 diabetes in the obese patient: current concerns and emerging therapies. Curr Med Res Opin 2008: 24: 401-17.
10. Krentz AJ, Patel MB, Bailey CJ. New drugs for type 2 diabetes mellitus: what is their place in therapy? Drugs 2008: 68: 2131-62.
11. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004: 21: 335-342.
12. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of Medicare coverage. Ann Intern Med 2009: 21: 505-515.
13. DCCT/EDIC Research Group. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration. Arch Intern Med 2009: 169: 1307-1316.
14. Sellers EA, Blydt-Hansen TD, Dean HJ, Gibson IW, Birk PE, Osborn M. Macroalbuminuria and renal pathology in First Nation youth with type 2 diabetes. Diabetes Care 2009: 32: 786-790.
15. Eppens MC, Craig ME, Jones TW, Silink M, Ong S, Ping YJ. International Diabetes Federation Western Pacific Region Steering Committee. Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Curr Med Res Opin 2006: 22: 1013-20.
16. Amiel SA, Sherwin RS, Simonson DC et al. Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986: 315: 215-219.
17. Wysocki T, Taylor A, Hough BS, Linscheid TR, Yeates KO, Naglieri JA. Deviation from developmentally appropriate self-care autonomy: Association with diabetes outcomes. Diabetes Care 1996: 19: 119-125.
18. Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: Relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr 1997: 130: 257-265.
19. Harris MA Wysocki T, Sadler M et al. Validation of a structured interview for the assessment of diabetes self-management. Diabetes Care 2000: 23: 1301-1304.
20. Thomas AM, Peterson J, Goldstein D. Problem solving and diabetes regimen adherence by children and adolescents with IDDM in social pressure situations: a reflection of normal development. J Pediatr Psychol 1997; 22: 541-561.
21. Allen DA, Tennen H, McGrade, BJ et al. Parent and child perceptions of the management of juvenile diabetes. J Pediatr Psychol 1983: 8: 129-141.
22. Palmer D, Berg CA, Wiebe DJ et al. The role of autonomy and pubertal status in understanding age difference in maternal involvement in diabetes responsibility across adolescence. J Pediatr Psychol 2004: 29: 35-46.
23. Weibe DJ, Berg, CA, Korbel C et al. Children's appraisals of maternal involvement in coping with diabetes: Enhancing our understanding of adherence, metabolic control, and quality of life across adolescence. J Pediatr Psychol 2005: 30: 167-178.
24. Shroff-Pendley J, Kasmen LJ, Miller DL et al. Peer and family support in children and adolescents with type 1 diabetes. J Pediatr Psychol 2002: 27: 429-438.
25. White NH, Waltman SR, Krupin E et al. Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control. Pediatrics 1981: 99: 41-45.
26. Nadeau K, Dabelea D. Epidemiology of type 2 diabetes in children and adolescents. In: Dabelea D, Klingensmith G, eds. Epidemiology of Pediatric and Adolescent Diabetes. New York: Informa Health Care, 2008: 103-123.
27. The SEARCH for Diabetes in Youth Study Group. The burden of diabetes among U.S. youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006: 118: 1510-1518.
28. Pinhas-Hamiel O, Standiford D, Hamiel D et al. The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med 1999: 153: 1063-1067.
29. Kovacs M, Goldston D, Obrosky DS et al. Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care 1997: 20: 36-44.
30. Kovacs M, Obrosky DS, Goldston D et al. Major depressive disorder in youths with IDDM: a controlled prospective study of course and outcome. Diabetes Care 1997: 20: 45-51.
31. Northam EA, Matthews LK, Anderson PJ et al. Psychiatric morbidity and health outcomes in type 1 diabetes - perspectives from a prospective longitudinal study. Diabetic Med 2005: 22: 152-157.
32. Blanz B, Rensch-Riemann B, Frotz-Sigmunc D et al. IDDM is a risk factor for adolescent psychiatric disorders Diabetes Care 1993: 16: 1579-1587.
33. Jacobson AM, Hauser ST, Willett JB et al. Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diabetes Care 1997: 20: 811-818.
34. Bryden KS, Peveler RC, Stein A et al. Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study. Diabetes Care 2001: 24: 1536-1540.
35. Gray M, Whittemore R, Tamborlane W. Depression in type 1 diabetes in children: natural history and correlates J Psychosom Res 2002: 53: 907-911.
36. The SEARCH for Diabetes in Youth Study Group. SEARCH for diabetes in youth: a multi-center study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 2004: 25: 458-471.
37. Lawrence JM, Standiford DA, Loots B et al. Prevalence and correlates of depressed mood among youth with diabetes: THE SEARCH for Diabetes in Youth Study. Pediatr 2006: 117: 1348-1358.
38. Dantzer C, Swendsen J, Maruice-Tison S et al. Anxiety and depression in juvenile diabetes: a critical review. Clinical Psychol Review 2003: 23: 787-800.
39. Hassan K, Loar R, Anderson BJ, Heptulla RA. The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J Pediatr 2006: 149: 526-531.
40. Lernmark B, Persson B, Fisher L et al. Symptoms of depression are important to psychological adaptation and metabolic control in children with diabetes mellitus. Diabetic Med 1999: 16: 14-22.
41. Rewers A, Chase HP, Mackenzie T et al. Predictors of acute complications in children with type 1 diabetes. JAMA 2002: 287: 2511-2518.
42. Stewart SM, Emslie GJ, Klein D et al. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus. Pediatrics 2005: 115: 1315-1319.
43. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-98.
44. Jones JM, Lawson ML, Daneman D et al. Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. Brit Med J 2000: 320: 1563-1566.
45. Rydall AC, Rodin GM, Osmsted MP et al. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 1997: 336: 1849-1854.
46. Goldston DB, Kelley AE, Reboussin DM et al. Suicidal ideation and behavior and noncompliance with the medical regimen among diabetic adolescents. J Am Acad Child Adol Psychiatry 1997: 36: 1528-1536.
47. Leonard BJ, Jang YP, Savik K et al. Psychosocial factors associated with levels of metabolic control in youth with type 1 diabetes. Pediatr Nursing 2002: 7: 28-37.
48. Wysocki T, Hough BS, Ward KM et al. Diabetes mellitus in the transition to adulthood: adjustment, self-care, and health status. J Dev Behav Pediatr 1992: 13: 194-201.
49. Cameron FJ, Northam EA. Childhood precursors of adolescent outcomes in type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2005: 18: 223-234.
50. Monaghan M, Singh C, Streisand R, Cogen FR. Screening and identification of children and adolescents at risk for depression during a diabetes clinic visit. Diabetes Spectrum 2010: 23:25-31.
51. Dabelea D. The accelerating epidemic of childhood diabetes. Lancet 2009: 13: 1999-2000.
52. Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL. The Peds QL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care 2003: 26: 631-637.
53. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008: 299: 2751-2759.
54. Drash AL, Becker D. Diabetes mellitus in the child: course, special problems, and related disorders. In Katzen H, Hajhler R, eds. Diabetes, Obesity and Vascular Disease: Advances in Modern Nutrition, vol. 2. New York: Wiley, 1978: 615-643.
55. Johns C, Faulkner MS, Quinn L. Characteristics of adolescents with type 1 diabetes who exhibit adverse outcomes. Diabetes Educ 2008: 34: 874-885.
56. Anderson BJ, Vangsness A, Connell A, Butler D, Goebel-Fabbri A, Laffel LMB. Family conflict, adherence and glycaemic control in youth with short duration type 1 diabetes. Diabetic Med 2002: 19: 635-642.
57. Swift EE, Chen R, Hershberger A, Holmes CS. Demographic risk factors, mediators and moderators in youths' diabetes metabolic control. Ann Behav Med 2006: 32: 39-49.
58. Fiese BH, Everhart RS. Medical adherence and childhood chronic illness: family daily management skills and emotional climate as emerging contributors. Curr Opin Pediatr 2006: 18: 551-557.
59. CDC.gov [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention. [Cited 2009 October 9] (available from).
60. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001: 24: 1069-1078.
61. Anderson BJ, Cullen K, McKay S. Quality of life, family behavior, and health outcomes in children with type 2 diabetes. Pediatr Ann 2005: 34: 722-729.
62. Pinhas-Hamiel O, Zeitler P. Barriers to the treatment of adolescent type 2 diabetes - a survey of provider perceptions. Pediatr Diabetes 2003: 4: 24-28.
63. Weissberg-Benchell J, Wolpert H, Anderson BJ. Transitioning from pediatric to adult care: a new approach to the post-adolescent young person with type 1 diabetes. Diabetes Care 2007: 30: 2441-2446.
64. American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians-American Society of Internal Medicine. A consensus statement on health care transitions for young adults with special health care needs. Pediatr 2002: 110: 1304-1306.
65. Society for Adolescent Medicine. Transition to adult health care for adolescent and young adults with chronic conditions. J Adolesc Health 2003: 33: 309-311.
66. de Beaufort C, Jarosz-Chobot P, Frank M, de Bart J, Deja G. Transition from pediatric to adult diabetes care: smooth or slippery? Pediatric Diabetes 2010: 11: 24-27.
67. Arnett JJ. Emerging adulthood: a theory of development from the late teens through the twenties. American Psychologist 2000: 55: 469-480.
68. Arnett JJ. Emerging adulthood: the winding road from the late teens through the twenties. New York: Oxford University Press, 2004.
69. Wolpert HW, Anderson BJ, Weissberg-Benchell J. Transitions in care: meeting the challenges of type 1 diabetes in young adults.Alexandria, VA: American Diabetes Association, 2009.
70. Peveler RC, Bryden KS, Neil HAW et al. The relationship of disordered eating habits and attitudes to clinical outcomes in young adult females with type 1 diabetes. Diabetes Care 2005: 28: 84-88.
71. Daneman D. State of the world's children with diabetes. Pediatr Diabetes 2009: 10: 120-126.
72. Cowie CC, Port FZK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989: 321: 1074-1079.
73. Araujo MB, Mazza CS. Assessment of risk factors of poor metabolic control in type 1 diabetic children assisted in a public hospital in Argentina. Pediatr Diabetes 2008: 9: 480-487.
74. Auslander WF, Thompson S, Dreitzer D, White NH, Santiago JV. Disparity in glycemic control and adherence between African-American and Caucasian youths with diabetes: family and community contexts. Diabetes Care 1997: 20: 1569-1575.
75. Institute of Medicine. Health literacy: A Prescription to End Confusion. Washington, DC: National Academies Press, 2004.
76. Osborn CT, White RO, Cavanaugh K, Rothman, Wallston KA. Diabetes numeracy: an overlooked factor in understanding racial disparities in glycemic control. Diabetes Care 2009: 32: 1614-1619.
77. Janisse HC, Naar-King S, Ellis D. Parent's health literacy among high-risk adolescents with insulin dependent diabetes. J Pediatr Psychol 2010: 35: 436-440.
78. Delamater AM, Albrecht DR, Postellon DC, Gutai JP. Racial differences in metabolic control of children and adolescents with type 1 diabetes mellitus. Diabetes Care 1991: 14: 20-25.
79. Hanson CL, Henggeler SW, Burghen GA. Race and sex differences in metabolic control of adolescents with IDDM: a function of psychosocial variables? Diabetes Care 1987: 10: 313-318.
80. Herman WH, Dungan KM, Wolffenbuttel BH et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1, 5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab 2009: 94: 1689-1694.
81. Rothman R, Mulvaney S, Elasy TA et al. Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes. Pediatr 2008: 121: e912-e919.